Bioburden, Sterility, and Endotoxin Testing: Three Different Questions in Peptide QC
Learn how bioburden, sterility, and endotoxin testing answer different contamination-control questions in research peptide quality review.
COA Literacy
Bioburden, Sterility, and Endotoxin Testing: Three Different Questions in Peptide QC
BetterBio Synthesis products are sold strictly for laboratory research use only. They are not drugs, foods, cosmetics, dietary supplements, or medical products. They are not intended for human or animal consumption, administration, diagnosis, treatment, cure, mitigation, or prevention of disease. This article is educational content for qualified researchers and does not provide medical advice.
Bioburden, sterility, and endotoxin testing are often grouped together, but they do not measure the same thing. For research peptide materials, understanding the difference helps researchers read COAs, evaluate quality claims, and avoid over-interpreting any single result.
Quality control language can sound deceptively simple. A peptide lot may be described as clean, tested, sterile, low endotoxin, or suitable for research, but those phrases do not all point to the same evidence. In contamination-control review, three terms deserve especially careful separation: bioburden, sterility, and endotoxin.
They are related because all three sit near the microbiology side of quality control. They are different because each test answers a different question.
Bioburden asks how many viable microorganisms are present before or during a controlled process. Sterility testing asks whether viable microorganisms can be detected under defined test conditions in a finished article or sample set. Endotoxin testing asks whether bacterial endotoxin, a nonliving pyrogenic component associated with Gram-negative bacteria, is present above a stated limit or reporting threshold.